| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212340 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 35 Pages |
Abstract
Pelvic radiation therapy with MMC plus capecitabine was well tolerated and appeared to have less grade 3+Â acute hematologic toxicity and fewer treatment interruptions than in a population of ASCC patients undergoing definitive chemoradiation with MMC and 5-FU.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karyn A. MD, MS, Diana MD, MPH, Andrea MD, Lajhem BA, Kaitlin M. MS, Zhigang PhD, Abraham J. MD, Diane L. MD, Neil H. MD, PhD, Zsofia K. MD, Leonard B. MD,